I-Mab Announces $418 Million Private Placement with Hillhouse Capital-Led Consortium

PRNewswire/ — I-Mab (the “Company”) (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that …
( read original story …)

---